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Understanding mechanisms of aging and determinants of life span will help to reduce age-related morbidity and
facilitate healthy aging. Average lifespan has increased over the last centuries, as a consequence of medical and
environmental factors, but maximal life span remains unchanged. Extension of maximal life span is currently
possible in animal models with measures such as genetic manipulations and caloric restriction (CR). CR appears to
prolong life by reducing reactive oxygen species (ROS)-mediated oxidative damage. But ROS formation, which is
positively implicated in cellular stress response mechanisms, is a highly regulated process controlled by a complex
network of intracellular signaling pathways. By sensing the intracellular nutrient and energy status, the functional
state of mitochondria, and the concentration of ROS produced in mitochondria, the longevity network regulates life
span across species by coordinating information flow along its convergent, divergent and multiply branched
signaling pathways, including vitagenes which are genes involved in preserving cellular homeostasis during
stressful conditions. Vitagenes encode for heat shock proteins (Hsp) Hsp32, Hsp70, the thioredoxin and the sirtuin
protein systems. Dietary antioxidants, have recently been demonstrated to be neuroprotective through the
activation of hormetic pathways, including vitagenes. The hormetic dose–response, challenges long-standing beliefs
about the nature of the dose–response in a lowdose zone, having the potential to affect significantly the design of
pre-clinical studies and clinical trials as well as strategies for optimal patient dosing in the treatment of numerous
diseases. Given the broad cytoprotective properties of the heat shock response there is now strong interest in
discovering and developing pharmacological agents capable of inducing stress responses. Here we focus on
possible signaling mechanisms involved in the activation of vitagenes resulting in enhanced defense against energy
and stress resistance homeostasis dysiruption with consequent impact on longevity processes.Introduction
Western Medicine is in crisis. Continually increasing
resources are being expended to combat the age-related
diseases that include diabetes and metabolic syndrome,
Alzheimer disease, and cancer. Yet, the causes of these
disease remain a mystery, while their incidence and
morbidity either remain constant or are increasing. Huge
investments in biomedical research in the recent past have
resulted in some striking accomplishments, including the
sequencing of the human chromosomal single nucleotide
polymorphisms (SNPs), and the identification of regional
clusters of chromosomal SNPs (the HapMap). However,* Correspondence: calabres@unict.it
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reproduction in any medium, provided the orthese accomplishments have failed to reveal the antici-
pated genetic causes for the common age-related diseases
[1-10].
While the anatomical paradigm of medicine and the
Mendelian paradigm of genetics have been powerful pre-
dictors of medical relationships for the past century, they
are failing to direct us toward solutions for the common
age-related disease. When a prevailing paradigm fails to
make productive predictions, then the hypothesis-based
research begins to fail. To resolve this crisis window and
to return to productive “normal science”, a new paradigm
must be generated which encompasses the failing strengths
of the previous paradigm but adds new elements address-
ing the current problems being confronted. Assuming that
this analysis is applicable to biomedical sciences, whatal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mendelian paradigms necessary for understanding the age-
related diseases remains still elusive. Mitochondrial biology
and genetics are being recognized as powerful candidate
for expanding anatomical and Mendelian paradigms to ad-
dress the complexities of the age-related diseases, aging
and cancer [11-15].
Life involves the interplay between structure and
energy. For the eukaryotic cell, this duality was cemented
approximately 2 billion years ago (earth is approximately
5 billion years old) by the symbiosis of what seems to have
been a glycolitic motile cell, which gave rise to the
nucleus-cytosol, and an oxidative proteobacterium, which
evolved into the mitochondrion. Initially each organism
was free living and contained all the genes for an inde-
pendent life. However. Over the subsequent 1.2 billion of
years, the single cell descendants of the original symbiosis
experimented many alternative rearrangements of bio-
medical interdependence and genomic reorganization.
This, ultimately, an arrangement was achieved in which
the mitochondrion became specialized in energy produc-
tion and the nucleus-cytosol polarized his specialization
twards structure. This final design prompted impetuously
the development of multicellularity and the evolution of
higher plants and animals, including humans. This ori-
ginal design powerfully comeback anytime in our cell
when tumor promotion occurs, whereby the glycolitic
imperatively dictates a kicking off process of mitochon-
drial energy process marginalitation, in favour of sustained
high proliferative potential of tumor progression. In this
scenario mitochondria acts as the ancient concept of
Asian medicine where “chi” stands for vital force of energy
[16-22].
Thus, understanding mechanisms of aging and determi-
nants of life span will help to reduce age-related morbidity
and facilitate healthy aging. Average lifespan has increased
over the last centuries, as a consequence of medical and
environmental factors, but maximal life span remains
unchanged [23]. Extension of maximal life span is
currently possible in animal models with measures such
as genetic manipulations and caloric restriction (CR). CR
appears to prolong life by reducing reactive oxygen species
(ROS)-mediated oxidative damage. But ROS formation,
which is positively implicated in cellular stress response
mechanisms, is a highly regulated process controlled by a
complex network of intracellular signaling pathways. By
sensing the intracellular nutrient and energy status, the
functional state of mitochondria, and the concentration of
ROS produced in mitochondria, the longevity network
regulates life span across species by coordinating informa-
tion flow along its convergent, divergent and multiply
branched signaling pathways, including vitagenes which
are genes involved in preserving cellular homeostasis dur-
ing stressful conditions. Vitagenes encode for heat shockproteins (Hsp) Hsp32, Hsp70, the thioredoxin and the
sirtuin protein systems [23]. Dietary antioxidants, have
recently been demonstrated to be neuroprotective through
the activation of hormetic pathways, including vitagenes.
The hormetic dose–response, challenges long-standing
beliefs about the nature of the dose–response in a lowdose
zone, having the potential to affect significantly the design
of pre-clinical studies and clinical trials as well as stra-
tegies for optimal patient dosing in the treatment of
numerous diseases [23]. Given the broad cytoprotective
properties of the heat shock response there is now strong
interest in discovering and developing pharmacological
agents capable of inducing stress responses. In this review
we discuss the most current and up to date understanding
of the possible signaling mechanisms by which caloric
restriction, as well hormetic caloric restriction-mimetics
compunds by activating vitagenes can enhance defensive
systems involved in bioenergetic and stress resistance
homeostasis with consequent impact on longevity pro-
cesses [24-30].
Hormesis and Longevity
Hormesis is a dose response phenomenon characterized
by a low dose stimulation and a high dose inhibition
(Figure 1). It may be graphically represented by either an
inverted U-shaped dose response or by a J- or U-shaped
dose response. The term hormesis was first presented in
the published literature in 1943 by Southam and Ehrlich
who reported that low doses of extracts from the Red
Cedar tree enhanced the proliferation of fungi with the
overall shape of the dose response being biphasic. How-
ever, credit for experimentally demonstrating the occur-
rence of hormesis belongs to Hugo Schulz (1888) [23]
who reported biphasic dose responses in yeast following
exposure to a large number of chemical disinfectant
agents. The work of Schulz encouraged numerous investi-
gators in diverse fields to assess whether such low dose
effects may be a general feature of biological systems. In
fact, similar types of dose response observations were sub-
sequently reported by numerous researchers assessing
chemicals [31] and radiation [32-34] with investigators
adopting different names such as the Arndt-Schulz Law,
Hueppe’s Rule, and other terms to describe these similar
dose response phenomena. Despite the rather substantial
historical literature concerning hormetic dose responses,
this concept had a difficult time being incorporated into
routine hazard assessment and pharmacological investiga-
tions, principally because it (i) required more rigorous
evaluation in the low dose zone, (ii) failure of investigators
to understand its clinical significance (iii) failure to ap-
preciate the quantitative features of the hormetic dose
response (iv) failure to understand the limitations of its
agricultural and industrial applications, (v) because of the
predominant interest in responses at relatively high doses
Maximum response
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Figure 1 Quantitative features of hormetic dose-response curve.
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ing, yet inappropriate, tendency to associate the concept
of hormesis with the medical practice of homeopathy [35].
However, since the late 1970’s there has been a growing
interest in hormetic-like biphasic dose responses across
the broad spectrum of biomedical sciences. This resur-
gence of interest resulted from a variety of factors, inclu-
ding the capacity to measure progressively lower doses of
drugs and chemicals, the adoption of cell culture methods
which has permitted more efficient testing of numerous
doses and the need to re-examine the validity of linear at
low dose modelling of cancer risks due to their enormous
cost implications for environmental regulations, as well
the astute observations of numerous independent in-
vestigators to generalize their hormetic findings across
biological systems [36,37].
The concept of hormesis is a central to the biomedical
sciences because of its generalizability [23,34,38]. Hormetic
dose responses are independent of biological model, end-
point as well as chemical class and physical agent [23]. In
direct head to head comparisons with the threshold and
linear dose response models the hormetic dose response
model was found in multiple studies with many thousands
of dose responses to make far more accurate predicts of
low dose responses [38]. The hormetic dose response has
also been shown to describe the fundamental features of
several dozen receptor systems, affecting a vast array of bio-
logical endpoints [34]. The concepts of pre-conditioning
and post-conditioning are also manifestations of hormesis.
When these two highly significant and general concepts are
analyzed within the dose response framework they conform
to the features of the hormetic dose response [31]. Of
particular importance is that the quantitative features of the
hormetic dose response are similar across biological models
and endpoints. This remarkable general feature of hormetic
dose response suggests that the hormetic dose responsemay represent the first comprehensively based quantitative
estimation of biological plasticity [35].
The failure to recognize and incorporate the concept
of hormesis as a central biological concept during the
key development period of dose response concept con-
solidation for pharmacology and toxicology during the
middle decades of the 20th century had many implica-
tions. For example, the failure to recognize the generality
of biphasic dose responses lead to the development of
toxicology becoming a high dose testing discipline that
also only tested few doses. It became a discipline that
developed flawed regulations based on an inadequate
understanding of the dose response that have inaccur-
ately estimated the costs and the benefits of such regula-
tions, thereby yielding an inadequate foundation for
public policy decisions [23]. Such historical failures lead
not only to the development of biologically unsupport-
able environmental regulations especially for carcinogens
but also profoundly slowed the recognition and genera-
lity of adaptive responses and how they might be
exploited within society. Not only was this failure highly
significant in the environmental realm but it also lead to
the failure of the biomedical community to adequately
test chemotherapeutic agents adequately. For example,
many anti-tumor agents that kill tumor cells at high
doses may also stimulate the proliferation of these cells
at lower doses, displaying the hormetic dose response
[38]. Furthermore, since the hormetic dose response has
clearly defined quantitative features and is highly
generalizable it also provides a quantitative estimate of
biological performance. That is, it estimates the extent
to which memory drugs can enhance learning. This con-
cept can be readily applied to all other areas of biological
performance such as bone strengthening, hair growth,
decreases in anxiety, plant growth and productivity and
others.
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hormesis concept can be used to understand the bio-
logical limits within which pharmaceutical efforts are
made to enhance the quality of aging and to affect
longevity. For example, the hormesis concept argues that
the biological performance can only be modestly im-
proved in all biological systems in most situations. The
term modestly is quantitatively constrained to be less
than two fold, with most maximal increases being within
the 30-60% range. Such biological constraints are of vital
importance to pharmaceutical companies and regulatory
agencies as they develop strategies for product develop-
ment and evaluation. This also suggests that attempts to
extend life would also be constrained within the bounds
of plasticity, which are quantitatively estimated by the
hormetic dose response. Thus, if the normal bounds of
human longevity are seen to be approximately as about
100 years, the hormesis concept predicts that it may be
possible to extend the human lifespan by 30–60 years at
most.
The data to support these types of biological cons-
trains are extensive. They are based on more than
20,000 dose responses in several hormesis databases.
These data sets are very general, including responses
across a very broad range of biological models and end-
points to a very large number of chemical agents
representing a broad spectrum of chemical classes. The
range and the scope of these findings have come a long
way in clarifying the limits within which biological
systems operate, the overlapping features of biological
control redundancies, and the constraints and flexibi-
lities within which cells, organs and organisms operate.
All of these features affect the extent to which humans
can manipulate biological systems and attempt to gain
improvement in function and performance. Thus, the
subsequent sections of this paper on cellular stress
responses and vitagenes all can and should be seen
within an hormetic context. Even the concept of wound
healing, which is essential to ensuring survival and
enhancing longevity are fundamentally described within
an hormetic context.
One of the best examples in rodents for chemical-
induced prolongation of life involves the effects of (−)
deprenyl. The life prolonging effects of (−)deprenyl has
been demonstrated in at least four different animal spe-
cies [23,34,38]. For example, (−)deprenyl has extended
the lifespan in male Logan-Wistar rats, male F-344 rats,
dogs, and mice and hamsters [23]. (−)Deprenyl has also
been shown to decrease longevity as well in a number of
species. When the toxicological findings of these nume-
rous studies was rationalized, what emerged was consist-
ent with the dose response pattern in which there was
enhancement of survival and prolongation of life at
lower doses but also a decrease in longevity at the higherdoses. It was concluded that the low dose enhanced
prolongation of lifespan by (−)deprenyl was an example
of hormesis. Follow up evaluations of (−)deprenyl on
axtioxidant enzymes (i.e., catalase, total SOD, CuZn
SOD and Mn SOD) one month before the end of a
27 month longevity study all reflected the hormetic
biphasic dose response activities in the striatum and cor-
tex areas of the brain. These enzymatic findings parallel
the longevity results, thus a possible causal association
between the anti-oxidant cellular activities and longevity
was suggested together with possible mechanism to
account for the hormetic effects. While more research is
needed to clarify the mechanisms for the enhanced
longevity at low dose, these findings also revealed that
the extensions of longevity were about 30-50% greater
than controls, observations fully consistent with the
hormetic dose response [23,34,38].
Cellular stress response, HSF biology and the Vitagene
network
Cellular stress response is the ability of a cell to counteract
stressful conditions (Figure 2a, Figure 2b). This pheno-
menon, which includes heat shock response (HSR), repre-
sents an ancient and highly conserved cytoprotective
mechanism [39-47]. Production of heat shock proteins,
including protein chaperones, is essential for the folding
and repair of damaged proteins, serving thus to promote
cell survival conditions that would otherwise result in apop-
tosis [36,48-51]. The term ‘molecular chaperone’ denotes a
large family of ubiquitous proteins that function as part of
an ancient defense system in our cells. Chaperones pro-
mote cell survival by sequestering damaged proteins and
preventing their aggregation. During stressful conditions,
such as elevated temperature, they prevent protein
aggregation by facilitating the refolding or elimination of
misfolded proteins. The stress-induced response to
damaged proteins is helped by a sophisticated regulatory
system, which shuts down most cellular functions and, in
parallel, induces the synthesis of several chaperones and
other survival-promoting proteins. Therefore, many of the
chaperones are also called stress or ‘heat shock’ proteins
in reference to the archetype of cellular stress, heat shock.
Besides their role during stress, chaperones have multiple
roles under normal conditions, as such they promote the
transport of macromolecules (e.g. proteins or RNA) and
participate in remodelling events involving larger protein
complexes, including signaling, transcription, cell division,
migration and differentia. Cellular stress response requires
the activation of pro-survival pathways which, under
control of protective genes called vitagenes [37] produce
molecules (heat shock proteins, glutathione, bilirubin)
endowed with anti-oxidant and anti-apoptotic activities.
Generally, molecular chaperones help a multitude of sig-
naling molecules to keep their activation-competent state,
Figure 2 a,b. Vitagenes and the pathway of cellular stress response. Cumulating misfolded proteins in response to proteotoxic
environmental stress conditions triggers the cellular stress response (Figure 2a). HSPs that are normally bound to HSF1, maintaining it in a
repressed state before stress, are titrate away by damaged or misfolded proteins with resulting HSF-1 activation. Multi-step activation of HSF1
involves post-translational modifications, such as hyperphosphorylation and deacetylation, which allow HSF1 to trimerize, translocate into the
nucleus, and bind to heat-shock elements (HSEs) in the promoter regions of its target hsp genes. Nutritional antioxidants, including carnosic acid,
resveratrol, sulforaphane, dimethyl fumarate, acetyl-L-carnitine or carnosine are able to activate vitagenes, such as heme oxygenase, Hsp70,
thioredoxin reductase and sirtuins which represent an integrated system for cellular stress tolerance. Phytochemicals and Acetyl-L-carnitine act
through the activation of the vitagene system, with up-regulation of HO-1, Thioredoxin, the GSH and Sirtuin system, results in counteraction of
pro-oxidant conditions (Figure 2b). During aging, a gradual decline in potency of the heat shock response occur and this may prevent repair of
protein damage, leading to degeneration and cell death.
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naling at the plasma membrane to transcription. In
addition to these specific regulatory roles, recent studies
have revealed that chaperones act as genetic buffers stabi-
lizing the phenotypes of various cells and organisms.
Among the cellular pathways conferring protection
against oxidative stress, a key role is played by the prod-
ucts of vitagenes [52-54]. These include members of the
heat shock protein (Hsp) family, such as heme oxygenase-
1 and Hsp72, sirtuins and the thioredoxin/thioredoxinreductase system [55]. Recent studies have shown that the
heat shock response contributes to establishing a cytopro-
tective state in a wide variety of human diseases, including
inflammation, cancer, aging and neurodegenerative disor-
ders [56]. Given the broad cytoprotective properties of the
heat shock response there is now strong interest in discov-
ering and developing pharmacological agents capable of
inducing the heat shock response [57]. Molecular chaper-
ones are known to disrupt aggregates but also to promote
active aggregation when the concentration of the
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although protein aggregation is hazardous under certain
circumstances, the creation of apparently less-toxic large
aggregates is protective. This hypothesis is the basis of the
therapeutic potential of heat shock proteins (HSPs), which
prevent protein misfolding and aggregation [58].
Cellular stress response is regulated at the transcrip-
tional, translational and post-translational levels by a
family of heat shock transcription factors (HSFs) that are
expressed and maintained in an inactive state under non-
stress conditions [59]. HSFs, essential for all organisms to
survive to acute or chronic stress, are also important for
normal development and lifespan-enhancing pathways,
and the repertoire of HSF targets has thus expanded well
beyond the heat shock genes. Post-translational regulation
of HSFs is emerging to integrate the metabolic state of the
cell with stress biology, whereby controlling fundamental
aspects of the health of the proteome and ageing. At the
transcriptional level the heat shock response is mediated
by cis-acting sequences called heat shock elements (HSEs)
present in multiple copies upstream of the HSP genes. In
contrast to a single HSF in invertebrates, multiple HSFs
are expressed in plants and vertebrates. Mammalian HSF
family consists of four members: HSF1, HSF2, HSF3 and
HSF4, which recognize by binding the heat shock element
(HSE), composed of inverted repeats of a consensus
nGAAn sequence. These distinct HSFs possess overlapping
functions, display tissue-specific patterns of expression,
undergoing multiple post-translational modifications, and
show various interacting protein partners. In addition to
thermal stress, the inducible expression of heat shock
proteins is also triggered by environmental redox changes
or exposure to electrophiles which cause trimerization and
DNA binding of HSF1, pointing to the importance of the
cysteine redox state for the activation of this transcription
factor [59]. Thus, an intermolecular disulfide bond for-
mation between C36 and C103 within HSF1 causes
trimerization and DNA binding, whereas an intramolecular
disulfide bond formation is inhibitory for the activity of the
transcription factor. Hence, pharmacologic modulation of
HSF-mediated gene regulation is an emerging area of
research which is increasing its potential based on the
current knowledge of small-molecule activators and inhibi-
tors of HSFs, so that the impact of HSFs is further
extending beyond the heat shock response, which possesses
the potential for attracting growing interest [60,61]. HSFs,
like other transcription factors, are composed of functional
domains which have been well characterized for HSF1. The
DNA-binding domain (DBD) belongs to the family of
winged helix-turn-helix DBDs. The DBD, the signature
domain of HSFs for recognition of target-genes, forms a
compact globular structure, except for a flexible wing or
loop, located between β-strands 3 and 4, which is respon-
sible for protein-protein interactions between adjacentsubunits of the trimerized HSF, conferring high-affinity
binding to DNA and mediating interactions with other
factors to modulate the transactivating capacity of HSFs.
The trimerization of HSFs is mediated by arrays of hydro-
phobic heptad repeats (HR-A and HR-B) forming coiled
coil, characteristic for many Leu zippers [61]. Trimerization
of HSF, facilitated by leu zippers is abrogated by another
hydrophobic repeat, HR-C located between the regulatory
and trans-activation domains (TADs). This latter, by
interacting with the HR-A/B domain prevents trimerization
maintaining HSF1 in an inactive status. The transactivation
domain in all HSFs is positioned at the extreme amino
terminus, and is composed of two modules — AD1 and
AD2, which are rich in hydrophobic and acidic residues
which allow rapid and prolonged response to stress
(61 57). Although the N-terminal parts of HSF1 mediate
trimer formation and acquisition of DNA-binding ability,
the C-terminal parts of the protein facilitate transcriptional
activation of target genes and also regulate the magnitude
of HSF1 activation [59,61]. Although the regulatory domain
of HSF has an intrinsic competence to sense heat stress, its
inducibility is modulated through posttranslational modifi-
cations [23,61]. Pharmacological inhibition of Hsp90 acti-
vity is sufficient to convert HSF1 into a DNA-binding
trimeric state in cells, thus in nonstressed cells, HSF1 is
maintained in an inactive monomeric state by interaction
with Hsp90. This interaction is rapidly reduced in cells
exposed to proteotoxic insults, where binding of HSF1 to
the promoter occurs within seconds and in about one
minute is saturated by the intervent of other positive signals
such as a ribonucleoprotein complex containing eukaryotic
elongation factor 1A (eEF1A) and a constitutive non-
coding RNA, heat shock RNA-1 (HSR-1), which has been
reported to possess a thermosensing capacity [62]. Con-
sistent with the proposed model, HSR-1 undergoes a
conformational change in response to heat stress facilitat-
ing, together with eEF1A, HSF1 trimerization. In this
activation cycle, HSF1 undergoes extensive post transla-
tional modifications, such as phosphorylation, sumoy-
lation and acetylation. Under unstressed conditions HSF1
is a phosphoprotein with at least 12 Ser residues are phos-
phorylated (S121, S230, S292, S303, S307, S314, S319,
S326, S344, S363, S419, and S444), with no detec-
table amount of threonine or tyrosine phosphorylation.
Phosphorylation-dependent sumoylation of HSF1 on
K298 requires a priming phosphorylation of S303. Phos-
phorylation of S303, possibly mediated by MAP kinases
(MAPK), facilitates HSF1 sumoylation by the SUMO E2
conjugating enzyme Ubc9, leading to repression of HSF1
trans-activating capacity. SUMO proteins resemble struc-
turally to ubiquitin and are transiently and covalently
bound to specific lysine (K) residues of multiple cellular
proteins. In many cases, sumoylation occurs on a consen-
sus sequence consisting of the tetrapeptide ΨKxE, in
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acid (usually a leucin, isoleucin, or valine) and K the
SUMO acceptor. In HSF1, adjacent consensus sequences
for sumoylation ΨKxE and phosphorylation (SP) together
form an extended target motif, ΨKxESP (PDSM), media-
ting phosphorylation-dependent sumoylation, acting not
only in the regulation of HSF biology, but also in a wide
range of transcriptional regulators, where SUMO proteins
are well-established repressors of transcription. While
phosphorylation and sumoylation of HSF1 occur rapidly
on heat shock, the kinetics of acetylation are delayed and
coincide with the attenuation phase of the HSF1 activation
cycle. Consistent with this notion, acetylation of HSF1
is regulated by the balance of acetylation by p300–
CBP (CREB-binding protein) and deacetylation by the
NAD+ −dependent sirtuin, SIRT1. Increased expression
and activity of SIRT1 enhances and prolongs the DNA-
binding activity of HSF1 at the human HSP70.1 promoter,
whereas downregulation of SIRT1 enhances the acetyl-
ation of HSF1 and the attenuation of DNA-binding with-
out affecting the formation of HSF1 trimers [23]. Thus
SIRT1 maintains HSF1 in a state that is competent for
DNA binding by counteracting acetylation . In the light of
current knowledge, the attenuation phase of the HSF1
cycle is regulated by a dual mechanism: a dependency on
the levels of HSPs that feed back directly by weak interac-
tions with HSF1, and a parallel step that involves the
SIRT1-dependent control of the DNA-binding activity of
HSF1. Because SIRT1 has been implicated in caloric
restriction and ageing, the age-dependent loss of SIRT1
and impaired HSF1 activity correlate with an impairment
of the heat shock response and proteostasis in senescent
cells, connecting the heat shock response to nutrition and
ageing [23].
Keap1/Nrf2/ARE biology and the Heme oxygenase pathway
of Stress tolerance
As mentioned above, a central regulator in the gene
expression of heat shock proteins is HSF1, however, in
addition to this some of the vitagenes are also upregulated
within the “phase 2 response”, known as “the electrophile
counterattack response”, a cytoprotective response that
protects against various electrophiles and oxidants [20-23].
Examples include heme oxygenase 1, thioredoxin and
thioredoxin reductase, all of which can be upregulated by
the transcription factor Nrf2 (Nuclear erythroid 2-related
factor 2) co-ordinately with a battery of cytoprotective
proteins, such as glutathione transferases (GST), UDP-
glucuronosyltransferase, NAD(P)H:quinone oxidoreductase
1 (NQO1), epoxide hydrolase, ferritin, γ-glutamylcysteine
synthetase, glutathione reductase, aldo-keto reductases, and
glutathione conjugate efflux pumps [20-23]. This elaborate
network of protective mechanisms allows eukaryotic organ-
isms to counteract the damaging effects of oxidants andelectrophiles, major agents involved in the pathogenesis of
cancer, atherosclerosis, neurodegeneration, and aging. The
gene expression of these cytoprotective proteins is coordi-
nately regulated by a common molecular mechanism that
involves the Keap1/Nrf2/ARE pathway. The upstream regu-
latory regions of these genes contain single or multiple cop-
ies of the antioxidant/electrophile response elements (ARE,
EpRE) with the consensus sequence 5’-A/CTGAC/
GNNNGCA/G-3’). The major transcription factor that
binds to the ARE is nuclear factor erythroid 2-related factor
2 (Nrf2), a basic leucine zipper transcription factor. Activa-
tion of gene expression requires that Nrf2 binds to the ARE
in heterodimeric combinations with members of the small
Maf family of transcription factors. Under basal conditions
the pathway operates at low levels due to the repressor
function of the cytosolic protein Kelch-like ECH-associated
protein 1 (Keap1), which binds to the E3 ubiquitin ligase
Cullin3-RING box1 (Cul3-Rbx1) and presents Nrf2 for
ubiquitination and subsequent proteosomal degradation.
Inducers of the Keap1/Nrf2/ARE pathway belong to at least
ten distinct chemical classes: (i) oxidizable diphenols,
phenylenediamines, and quinones; (ii) Michael acceptors
(olefins or acetylenes conjugated to electron-withdrawing
groups); (iii) isothiocyanates; (iv) thiocarbamates; (v) triva-
lent arsenicals; (vi) dithiolethiones; (vii) hydroperoxides;
(viii) vicinal dimercaptans; (ix) heavy metals; and (x) poly-
enes. The only common property among them is their
chemical reactivity with sulfhydryl groups by oxido-
reduction, alkylation, or disulfide interchange. A large num-
ber of in vivo experiments have demonstrated the
neuroprotective role of the Keap1/Nrf2/ARE pathway and
suggested the potential use of Nrf2 inducers for achieving
protection against neurodegenerative diseases. Thus, in
comparison to wild-type mice, nrf2-knockout mice are
hypersensitive to the mitochondrial complex II inhibitors
3-nitropropionic acid and malonate which induce lesions in
the striatum. Nrf2-knockout mice are also more susceptible
to seizures, neuronal damage and microglial infiltration in
hippocampus induced by kainic acid exposure [20-23].
Nrf2-dependent protection against excess release of dopa-
mine was also recently reported [20-23]. Transplanted
Nrf2-overexpressing astrocytes into the mouse striatum
prior to challenge with malonate provided dramatic protec-
tion against malonate-induced neurotoxicity and remark-
ably, brain hemispheres receiving Nrf2-producing astrocyte
transplants were essentially resistant to malonate toxicity,
whereas hemispheres receiving control astrocytes were no
different from untransplanted controls. Among the various
redox regulated Vitagenes, containing in its promoter re-
gion the antioxidant response element (ARE), there has
been a growing interest over the last years in the heme oxy-
genase (HO) system, the family of enzymes that control the
initial and rate-limiting steps in heme catabolism [20-23].
The heme oxygenases have been recognized as dynamic
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homeostasis throughout the phylogenetic spectrum. Heme
oxygenases are located within the endoplasmic reticulum
where they act in association with NADPH cytochrome
P450 reductase to oxidize heme to biliverdin, free ferrous
iron and carbon monoxide (CO. Biliverdin reductase fur-
ther catabolizes biliverdin to the bile pigment, bilirubin, a
linear tetrapyrrole which has been shown to effectively
counteract nitrosative stress due to its ability to interact
with NO and RNS [20-23]. Bilirubin is then conjugated
with glucuronic acid and excreted [20-23]. Bilirubin has
been shown to serve as an endogenous scavenger for both
nitric oxide and reactive nitrogen species, which may alter
the redox status of the cell and originate nitrosative stress
[20-23]. Despite this important antioxidant properties, if
produced in excess, as in the case of haemolytic anaemia
or sepsis, unconjugated bilirubin becomes neurotoxic
through multiple mechanisms involving the disruption of
cell membrane structure, the reduction of mitochondrial
transmembrane potential and the activation of the apop-
totic cascade [20-23]. Mammalian cells express at least
two isoforms of HO, HO-1 and HO-2. A third protein,
HO-3, determined to be a retrotransposition of the HO-2
gene (pseudogene) has been found unique to rats. Al-
though HO-1 and HO-2 catalyze the same reaction, they
play different roles in protecting tissues against injury. A
convincing hypothesis suggests that HO-1 induction is one
of the earlier cellular response to tissue damage and is re-
sponsible for the rapid clearance of the intracellular pro-
oxidant heme and its transformation into CO and biliverdin
the latter being the precursor of the antioxidant bilirubin.
On the contrary, constitutively expressed HO-2 is primarily
involved in maintaining cellular heme homeostasis as well
as in the sensing of intracellular levels of gaseous com-
pounds including NO and CO. Due to the antioxidant re-
sponse element (ARE) contained in its promoter region,
redox regulation of HO-1 gene is now well defined [20-23].
HO-1, in fact, can be induced by several stimuli associated
with oxidative and/or nitrosative stress, such as heme, Aβ,
dopamine analogues, H2O2, hyperoxia, UV light, heavy
metals, prostaglandins, NO, peroxynitrite, Th1 cytokines,
oxidized lipid products and lipopolysaccharide, as well as
certain growth factors. The induction of ho-1 is regulated
principally by two upstream enhancers, E1 and E2. Both
enhancer regions contain multiple stress (or antioxidant)
responsive elements (StRE, also called ARE) that also con-
form to the sequence of the Maf recognition element
(MARE) [63] with a consensus sequence (GCnnnGTA)
similar to that of other antioxidant enzymes. Polymor-
phisms in the lengths of GT repeats [11-40] within the
HMOX1 promoter appear to be an important determinant
of HO-1 expression and function in humans. Long GT se-
quences code for relatively unstable (Z-conformational)
DNA with attenuated transcriptional activity anddiminished baseline and stimulated HO-1 protein expres-
sion profiles. Significantly higher HO-1 activity is associated
with the short-GT polymorphisms which may protect
against atherosclerosis-linked conditions (e.g. coronary ar-
tery disease), whereas the malignant behavior of various
neoplasms was fairly consistently enhanced by the short-
GT form. Due to its strong antioxidant properties and wide
distribution within the CNS, HO-1 has been proposed as a
key enzyme in the prevention of brain damage [64]. The
neuroprotective effects of over-expressed HO-1 can be at-
tributed to: (i) increase in cGMP and bcl-2 levels in neu-
rons; (ii) inactivation of p53, a protein involved in
promoting cell death; (iii) increase in antioxidant sources
and (iv) increase in the iron sequestering protein, ferritin.
Specifically, the interaction between HO-1, p53 and Bcl2
could involve the “heme-regulating motifs” of HO-2, which
could modulate gene expression by promoting oxygen rad-
ical formation and acting as a “sink” for NO. In the absence
of elevated intracellular heme or oxidative stress, the basic
region leucine zipper transcriptional regulator BACH1
binds HMOX1 antioxidant response elements and re-
presses transcription. Conversely, increased intracellular
heme or sulfhydryl oxidation inactivate BACH1, permitting
transcriptional induction of HMOX1. Although it is gener-
ally agreed that increased HO-1 expression is a common
feature during oxidative stress, recent papers demonstrated
that HO-1 can be repressed during oxidative stress condi-
tions. In particular human cells exposed to hypoxia, ther-
mal stress and interferon-γ showed a marked HO-1
repression. The importance of HO-1 repression has been
corroborated by the discovery of Bach1/Bach2 as heme-
regulated transcription factors for HO-1 gene. In fact,
Bach1 is broadly expressed in mice and human tissues and,
in human cells, it is induced by the same stimuli which are
able to repress HO-1 gene [23]. Current hypothesis sug-
gests that HO-1 repression is useful for the cell because
(i) decreases the energy costs necessary for heme degrad-
ation, (ii) reduces the accumulation of CO and bilirubin
which can become toxic if produced in excess and (iii) in-
creases the intracellular content of heme necessary for the
preservation of vital functions such as respiration [55,59].
Particularly interesting is the role played by HO-1 in AD, a
neurodegenerative disorder which involves a chronic in-
flammatory response associated with both oxidative brain
injury and Aβ-associated pathology. Significant increases in
the levels of HO-1 have been observed in AD brains in as-
sociation with neurofibrillary tangles and also HO-1 mRNA
was found increased in AD neocortex and cerebral vessels;
the HO-1 increase also co-localized with senile plaques and
glial fibrillary acidic protein-positive astrocytes in AD
brains. It is plausible that the dramatic increase in HO-1 in
AD may be a direct response to an increase in free heme
concentrations, associated with neurodegeneration, and can
be considered as an attempt of brain cells to convert the
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The protective role played by HO-1 and its products in AD
raised new possibilities regarding the possible use of natural
substances, which are able to increase HO-1 levels, as po-
tential drugs for the prevention and treatment of AD. In
this light very promising are the polyphenolic compounds
contained in some herbs and spices, e.g. curcumin.
Curcumin is the active anti-oxidant principle in Curcuma
longa, a colouring agent and food additive commonly used
in Indian culinary preparations. This polyphenolic sub-
stance has the potential to inhibit lipid peroxidation and to
effectively intercept and neutralize ROS and RNS. In
addition, curcumin has been shown to significantly increase
HO-1 in astrocytes and vascular endothelial cells. This lat-
ter effect on HO-1 can explain, at least in part, the anti-
oxidant properties of curcumin, in particular keeping in
mind that HO-1-derived bilirubin has the ability to scav-
enge both ROS and RNS. Epidemiological studies suggested
that curcumin, as one of the most prevalent nutritional and
medicinal compounds used by the Indian population, is re-
sponsible for the significantly reduced (4.4- fold) prevalence
of AD in India compared to United States [23,55,59].
Based on these findings, Lim and colleagues have
provided convincing evidence that dietary curcumin given
to an AD transgenic APPSw mouse model (Tg2576) for
6 months resulted in a suppression of indices of inflamma-
tion and oxidative damage in the brain of these mice [65].
Furthermore, increasing evidence indicates that curcumin
inhibits NFkB activation, efficiently preventing cell death
[64,66,67]. Whereas the acute induction of this enzyme in
neural and other tissues is predominantly cytoprotective in
nature, protracted or repeated up-regulation of the Hmox1
gene in astrocytes, oligodendroglia and possibly neurons
may perpetuate cellular dysfunction and demise in many
chronic degenerative and neuroinflammatory conditions
long after provocative stimuli iniziation. Within this con-
text, heme-derived free ferrous iron, CO, and biliverdin/
bilirubin are all biologically active substances that can either
ameliorate or exacerbate neural injury contingently to the
specific disease conditions, such as intensity and duration
of HO-1 expression and/or the nature of the resulting
redox milieu [68-71]. In ‘stressed’ astroglia, HO-1 hyper-
activity promotes mitochondrial sequestration of non-
transferrin iron and macroautophagy and may thereby
contribute to the pathological iron deposition and bioener-
getic failure found in most age-related oxidant neurodegen-
erative disorders. Glial HO-1 expression may impact also
cell survival and neuroplasticity by modulating brain sterol
metabolism and proteosomal degradation of neurotoxic
protein aggregates [72].
The mitochondrial theory of aging
Mitochondria are membrane-enclosed organelles found
in eukaryotic cells where they generate ATP as a sourceof chemical energy. ATP synthesis occurs through the
respiratory or electron transport chain (ETC.) located at
the inner mitochondrial membrane, and consists of five
protein complexes (Complexes I–V) [13,17,21,31,35,59].
Besides supplying ATP, mitochondria are involved in
many other cell functions including the biosynthesis of
heme, cholesterol and phospholipids [13,17,21,31,35,59]
and initiation of the apoptotic process [13]. According
to the endosymbiosis theory, mitochondria are organ-
elles that evolved from purpurbacteria approximately 1.5
billion years ago. Mitochondria have their own genome
[31] and can replicate and transcribe their DNA semi-
autonomously. Mitochondrial DNA (mtDNA), like
nuclear DNA, is constantly exposed to DNA damaging
agents. For many years it was thought, in mtDNA repair,
that excessively damaged mtDNA molecules were simply
degraded and replaced by newly-generated successors
copied from undamaged genomes. However, findings
now indicate that mitochondria possess the machinery
needed to repair genome damage caused by endogenous
or exogenous harmful agents. Harman [35,51] suggested
that free radicals are involved in the aging process and
that mitochondria-derived ROS may influence cellular
aging [35,51]. The treatment of IMR-90 fibroblasts with
N-tertbutyl hydroxylamine, (an antioxidant recycled by
the mitochondrial electron-transport chain) initially gave
support to the theory of mitochondrial involvement in
cellular senescence. N-tert-butyl hydroxylamine extends
fibroblast replicative capacity and delays changes in mito-
chondrial function due to age by reducing ROS production,
preservation of mitochondrial membrane potential and by
increasing the cellular GSH/GSSG ratio [35]. A more re-
cent study has demonstrated that mitochondria derived
ROS play an important and direct role in the shortening of
telomeres and the onset of senescence [59]. Other findings
have proposed that mitochondrial dysfunction leads to
mitochondrial biogenesis, thereby increasing the number of
cell sites for the production of ROS that causes telomere
shortening [13,17,21,31,35,59].
On account of its elevated mutagenic propensity, accu-
mulation of mtDNA during life is thought to be a major
cause of age-related disease. The lack of introns and
protective histones, limited nucleotide excision and
recombination DNA repair mechanisms, location in
proximity of the inner mitochondrial membrane with ex-
posure to an enriched free radical milieu are all factors
contributing to a mutation rate that is 10-fold higher in
the mtDNA than in the nuclear DNA (nDNA) [21,35].
Furthermore, considerable evidence suggests that mtDNA
mutations increase as a function of age, reaching the
highest levels in brain and muscle. It has been reported
that more than twenty different types of deletions accu-
mulate in aging human tissues. The first report on an age-
related increase in a mtDNA deletion was found in elderly
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the “common deletion”, was observed between 13-bp se-
quence repeats beginning at nucleotides 8470 and 13447,
removing almost a 5-kb region of mtDNA between
ATPase 8 and the ND5 genes. The deletion takes place
during replication of the mtDNA, the missing sequence
encodes for six essential polypeptides of the respiratory
chain and 5 tRNAs, and has been associated with several
clinical diseases, such as chronic progressive external
ophthalmoplegia and Kearns Sayre syndrome. In a com-
parison with age-matched controls, an association was
found between numerous age-related disorders and higher
levels of mtDNA mutations. In the central nervous system
(CNS), patients with Parkinson’s disease were found to
have a 17 times higher level of the common deletion in
the striatum, compared to age-matched controls. There is
also evidence of higher levels of this deletion in patients
with Alzheimer’s disease, parallelling increased levels in
the oxidized nucleotide 8-OH-dG [13]. More than 100
mutations of mtDNA have been associated with human
diseas [59]. Phenotypic manifestation of mtDNA muta-
tions is extremely broad ranging from oligosymptomatic
patients with isolated deafness, diabetes, ophthalmoplegia,
etc., to complex encephalomyopathic disorders that may
include dementia, seizures, ataxia, stroke-like episode and
so on. There is also a wide range of genotype variants,
with rearrangements (deletions, duplications) and point
mutations affecting protein coding genes, tRNAs and
rRNAs. Although there are some broad genotype/
phenotype correlations, considerable overlap also occurs.
Further research is needed to fully understand the patho-
genetic mechanisms involved in the expression of mtDNA
mutations. Recent studies have identified mutations of
nuclear genes encoding subunits of the respiratory chain,
particularly those of complex I. These principally involve
infant onset disease with early death. Moreover recent
research has shown that the function of the respiratory
chain may be impaired by mutations affecting other mito-
chondrial proteins or as a secondary phenomenon to
other intracellular biochemical derangements. An example
is Friedreich ataxia where a mutation of a nuclear encoded
protein (frataxin), probably involved in iron homeostasis
in mitochondria, results in severe deficiency of the respira-
tory chain in a pattern indicative of free radical mediated
damage [21,35,59].
Mutations of nuclear encoded proteins involved in
cytochrome oxidase assembly and maintenance have
been identified. As predicted, they are associated with
severe deficiency of cytochrome oxidase and Leigh syn-
drome. Defects of intracellular metabolism, particularly
with excess-free radical generation including nitric oxide
or peroxynitrite, may cause secondary damage to the
respiratory chain. This probably plays an important role in
Huntington disease, motor neuron disease (amyotrophiclateral sclerosis) and Wilson disease. It is important to
consider however that mutation and ROS induced DNA
damage are different, and the diseases mentioned above
are mostly dependent on genetics and not a causative
factor of oxidative stress. Since a common pathway in the
pathogenesis of these disorders appears to be defective
oxidative phosphorylation, treatments designed to im-
prove respiratory chain function may bring amelioration
in the progression of these disorders [23]. These findings
establish that a key feature of the aging process is the rela-
tionship between age-associated accumulation of mtDNA
mutations and bioenergy dysfunction, at least in tissues
predominantly composed of postmitotic cells, such as
CNS and skeletal muscle [31].
With regard to mitochondrial bioenergetics, a signifi-
cant decrease in state 3/state 4 ratio has been seen to
occur in brain during aging [21]. Since this ratio relates
to the coupling efficiency between electron flux through
the electron transport chain and ATP production, an
increase in state 4 would reduce mitochondrial com-
plexes and consequently increase free radical species
production. A decrease in state 3/state 4 respiration
during aging has been associated with a significant
decrease in cardiolipin content in brain mitochondria
[31]. This loss may play a vital role in age-related reduc-
tion in mitochondrial function, and appears to be associ-
ated with both quantitative and qualitative region-specific
protein changes such as decrease of the inner membrane
surface, smaller and fewer cristae, decreased fluidity and
increased fragility. Is known that functional changes in
brain mitochondria are correlated with modifications in
cardiolipin composition. Acetylcarnitine fed to old rats
increased cardiolipin to levels found in young rats and
restored protein synthesis both in the inner mitochondrial
membrane and cellular oxidant/antioxidant balance,
suggesting that cellular bioenergetics in aged rats may
benefit from administration of this compound [35]. It is
interesting to note that caloric restriction, a dietary regi-
men that increases life-span in rodents, maintains the
levels of 18:2 acyl side chains and inhibits cardiolipin com-
position changes [59]. It has also been shown to retard
aging associated changes in oxidative damage, mito-
chondrial oxidant generation and antioxidant defenses
observed during aging [13,17,21,35,59].
Recent finding indicates that calorie restriction and
specifically reduced glucose metabolism induce mito-
chondrial metabolism to extend life span in a number of
model organisms including Saccharomyces cerevisiae,
Drosophila melanogaster, Caenorhabditis elegans and
possibly mice. In contrast with Harman's free radical
theory of aging, these effects may be caused by an
increase in ROS formation within the mitochondria
leading to an adaptive response that culminates in
increased stress resistance thought to ultimately cause a
Cornelius et al. Immunity & Ageing 2013, 10:15 Page 11 of 13
http://www.immunityageing.com/content/10/1/15long-term reduction in oxidative stress [31]. This type of
retrograde response, termed mitochondrial hormesis or
mitohormesis, may be involved in the health-promoting
effects of physical exercise in humans and, hypothetic-
ally, impaired insulin/IGF-1-signaling in model organ-
isms. Abrogation of this mitochondrial ROS signal by
antioxidants consistently impairs the lifespan-extending
and health-promoting capabilities of glucose restriction
and physical exercise, respectively [31]. In short, ROS
are essential signaling molecules needed to promote
health and longevity. The concept of mitohormesis there-
fore provides a common mechanistic denominator for the
physiological effects of physical exercise, reduced calorie
uptake and glucose restriction [23]. Consistent with this
notion, calorie restriction slows the progression of age-
related diseases, extending the lifespan of many species
and, in addition, dietary supplementation with essential
and/or branched chain amino acids (BCAAs) has been re-
cently demonstrated to support cardiac and skeletal
muscle mitochondrial biogenesis, thereby preventing oxi-
dative damage and enhancing physical endurance in
middle-aged mice, with resulting prolonged survival [73].
Conclusions and future directions
Mitochondria are major cellular sources (and targets) of
free radicals, play key roles in the regulation of calcium
homeostasis, and are effectors of the intrinsic apoptotic
pathway due to the release of signaling molecules that ac-
tivate and trigger specific caspase cascades. Mitochondrial
dysfunction is inherent in a variety of human disorders
from the classical mitochondrial diseases arising from
mitochondrial DNA mutations (encephalomyopathies) to
those involving mitochondrial signaling pathways to the
rest of the cell, modulated by organellar dynamics and
culminating in programmed cell death. The role of mito-
chondria in normal aging has been the focus of extensive
research in the last decades and being complementary to
and maturing from the free radical theory of aging, to the
oxidative stress theory of aging, to the mitochondrial
oxidative stress theory of aging, and today addressing the
tight co-regulation of mitochondrial energy and redox
signaling. Consistent with this notion, the emerging role
of the carnitine system in counteracting metabolic distur-
bances present in neurological diseases has become appar-
ent [12,13]. While carnitine’s most widely known function
is its involvement in b-oxidation of fatty acids, it may also
have other roles in metabolism. Functions of carnitine and
acylcarnitines in fatty acid metabolism, ketosis and buffer-
ing of the concentration ratio of acyl-CoA to free CoA,
are significant in brain metabolism, particularly under
conditions associated with neurodegenerative damage. In
this scenario, it appears conceivably the function of the
carnitine system as a prototypical vitagene operating at
the functional interface of energy distribution betweenancestral mechanisms of cell proliferation and differenti-
ation and homeostatic mitochondrial dependent processes
of cell survival which require energy for cellular stress
response and redox homeostasis [23]. Very importantly,
new envisioned role exploited for mitochondrial targeted
compounds, such as nutritional antioxidants, carnitines or
carnosine which, by intersecting convergent mechanisms
that rely on cellular energy distribution and availability,
such as cellular stress response pathways, DNA repair and
molecular fidelity mechanisms, as well as maintenance of
optimum antioxidant potential appear to be a promising
novel therapeutic approach for those pathophysiological
conditions, such as neurodegeneration or cancer, where
hormetic stimulation of the vitagene pathway is strongly
warranted. Healthy ageing involves the interaction between
genes, the environment, and lifestyle factors, particularly
diet. Besides evaluating specific gene-environment interac-
tions in relation to exceptional longevity, it is important to
focus attention on modifiable lifestyle factors such as diet
and nutrition to achieve extension of health span. Thus, a
better understanding of nutrient-sensing pathways that
have been proven to have a pivotal role in the regulation of
life span [74], a better characterization of metobolomics
and dietary patterns in centenarians will help to better
understand human longevity and assist in the design of
strategies to extend the duration of optimal human health.
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